STACEY LOMBARDO: Open Payments
NPI 1891245916 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,341 in 105 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,711 · 2025 $3,341
Food & beverage: $3,241Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $834 |
| LEO Pharma Inc. | 15 | $664 |
| Janssen Biotech, Inc. | 10 | $239 |
| Galderma Laboratories, L.P. | 7 | $226 |
| ABBVIE INC. | 26 | $217 |
| Amgen Inc. | 4 | $181 |
| PFIZER INC. | 5 | $170 |
| Incyte Corporation | 6 | $140 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $139 |
| GENZYME CORPORATION | 4 | $108 |
Products named: Bimzelx, ANZUPGO, ADBRY, DUPIXENT, TREMFYA, NEMLUVIO, OTEZLA, SKYRIZI.
Industry payments across CT — which companies pay providers there.
